91 related articles for article (PubMed ID: 7686235)
1. [Acquired inhibitors (autoantibodies) to coagulation factors in non-hemophilic patients].
Okamura T; Tsuda H
Rinsho Ketsueki; 1993 May; 34(5):583-7. PubMed ID: 7686235
[TBL] [Abstract][Full Text] [Related]
2. [Acquired inhibitors to coagulation factors].
Okamura T
Rinsho Byori; 1994 Jan; 42(1):3-8. PubMed ID: 8107280
[TBL] [Abstract][Full Text] [Related]
3. Immunological analysis of acquired factor VIII inhibitor in a case with immunologic disorder.
Okamura T; Yamauchi Y; Fukuda T; Suehiro K; Murakawa M; Shibuya T; Nagasawa K; Harada M; Niho Y
Acta Haematol; 1991; 85(3):153-5. PubMed ID: 1710410
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical characterization of antibodies to factor VIII in hemophilic and nonhemophilic patients.
Allain JP; Gaillandre A; Lee H
J Lab Clin Med; 1981 Jun; 97(6):791-800. PubMed ID: 6785371
[TBL] [Abstract][Full Text] [Related]
5. [Factor VIII epitopes recognized by inhibitors in hemophiliacs].
Hayashi T; Niiya K; Sakuragawa N; Ichihara K; Yamazaki T; Watanabe A
Rinsho Ketsueki; 1991 Sep; 32(9):945-50. PubMed ID: 1719257
[TBL] [Abstract][Full Text] [Related]
6. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
[TBL] [Abstract][Full Text] [Related]
7. [Clinical cases of acquired coagulation inhibitors].
Yamane T; Hino M; Ota K; Akahori M; Hirai M; Inoue T; Mugitani A; Tatsumi N
Rinsho Byori; 2000 Dec; 48(12):1093-101. PubMed ID: 11215417
[TBL] [Abstract][Full Text] [Related]
8. Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.
Lopaciuk S; Bykowska K; McDonagh JM; McDonagh RP; Yount WJ; Fuller CR; Cooperstein L; Gray A; Lorand L
J Clin Invest; 1978 May; 61(5):1196-203. PubMed ID: 96136
[TBL] [Abstract][Full Text] [Related]
9. Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli.
Scandella D; DeGraaf Mahoney S; Mattingly M; Roeder D; Timmons L; Fulcher CA
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6152-6. PubMed ID: 2457907
[TBL] [Abstract][Full Text] [Related]
10. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.
Hay CR; Ludlam CA; Colvin BT; Hill FG; Preston FE; Wasseem N; Bagnall R; Peake IR; Berntorp E; Mauser Bunschoten EP; Fijnvandraat K; Kasper CK; White G; Santagostino E
Thromb Haemost; 1998 Apr; 79(4):762-6. PubMed ID: 9569189
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of factor VIII inhibitors in a previously untreated mild haemophilia A patient with an Arg593-->Cys substitution.
van den Brink EN; Timmermans SM; Turenhout EA; Bank CM; Fijnvandraat K; Voorberg J; Peters M
Thromb Haemost; 1999 May; 81(5):723-6. PubMed ID: 10365744
[TBL] [Abstract][Full Text] [Related]
12. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
[TBL] [Abstract][Full Text] [Related]
13. [Characterization of the factor VIII inhibitor in a patient with chronic renal failure].
Uemura Y; Niiya K; Takeuchi T; Miyoshi I
Rinsho Ketsueki; 1991 Jan; 32(1):39-42. PubMed ID: 1708430
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical characterization of factor VIII inhibitors.
Hoyer LW; Gawryl MS; de la Fuente B
Prog Clin Biol Res; 1984; 150():73-85. PubMed ID: 6431443
[TBL] [Abstract][Full Text] [Related]
15. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].
Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E
Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386
[TBL] [Abstract][Full Text] [Related]
16. [Immune coagulation disorders (excluding antiphospholipid syndrome].
Arai M
Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
[TBL] [Abstract][Full Text] [Related]
17. The immunological characterization of human antibodies to factor VIII isolated by immuno-affinity chromatography.
Kavanagh ML; Wood CN; Davidson JF
Thromb Haemost; 1981 Feb; 45(1):60-4. PubMed ID: 6787728
[TBL] [Abstract][Full Text] [Related]
18. [Development of factor VIII inhibitor in three non-hemophiliac patients].
Kiguchi T; Niiya K; Yamawaki Y; Shima M; Harada M
Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439
[TBL] [Abstract][Full Text] [Related]
19. Acquired hemophilia.
Bouvry P; Recloux P
Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
[TBL] [Abstract][Full Text] [Related]
20. Human anti-factor VIII antibodies: epitope localization and inhibitory function.
Scandella D
Vox Sang; 1996; 70 Suppl 1():9-14. PubMed ID: 8869462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
